Day: March 20, 2025

Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the aggregate over the next decade assuming a 2029 launch Ramat Gan, Israel, March 20, 2025 (GLOBE NEWSWIRE) —  Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced that its veterinary partner Vetbiolix is initiating an advanced clinical study in dogs with osteoarthritis, utilizing oral daily treatment with Piclidenoson. As previously reported, Vetbiolix concluded successfully a clinical study in dogs with osteoarthritis who were treated orally with Piclidenoson for a two months period. The arthritis market for companion animals is estimated...

VANCOUVER, British Columbia and WILMINGTON, Mass., March 20, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: LD2A), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, is pleased to announce that is has closed the previously announced over-night marketed public offering of 3,031,000 units (the “Units”) at the price of $1.65 per Unit for gross proceeds of $5,001,150 (the “Offering”). Canaccord Genuity Corp. (the “Underwriter”) acted as underwriter for the Offering. Each Unit comprised of one common share of the Company (each a “Share”) and one-half of one Share purchase warrant (each whole Share purchase warrant, a “Warrant”). Each Warrant entitles the holder to acquire one Share at an exercise price...

Intersected 5.68 g/t Au over 10.72 m, including 19.05 g/t Au over 2.00 m in the Jubilee Shear TORONTO, March 20, 2025 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to announce gold (“Au”) assay results from four (3) drill holes for 1,487 metres (“m”) of assayed drill core completed as part of its ongoing, fully funded 25,000 m drill program at its Wawa Gold Project, Ontario. HighlightsStep-out drilling at the Jubilee Shear intersected 5.68 g/t Au over 10.72 m, including 19.05 grams per tonne (“g/t”) Au over 2.00 m, which is 600 m down plunge from previous drilling Drilling at the Jubilee Shear indicates that newly discovered high-grade shoot could extend over more than 940 m Near surface drilling at the past producing Parkhill Mine, located in the Hanging Wall...

FALLS CHURCH, Va., March 20, 2025 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) announced today that its first quarter 2025 financial results will be posted on its investor relations website on Tuesday, April 22, 2025. Prior to the market opening, the company will issue an advisory release notifying the public of the availability of the complete and full text earnings release on the company’s website at http://investor.northropgrumman.com. The company’s first quarter 2025 conference call will be held at 9:30 a.m. Eastern time, Tuesday, April 22, 2025. The conference call will be webcast live on Northrop Grumman’s website at http://investor.northropgrumman.com. Replays of the call will be available on the Northrop Grumman website for a limited time. Presentations may be supplemented by a series of slides appearing...

Golar LNG Limited (“Golar”) is pleased to announce that it has entered into finance lease agreements with a consortium of leading Chinese leasing companies for the refinancing of the existing FLNG Gimi debt facility. The sale leaseback facility will be approximately $1.2 billion. The transaction is subject to closing conditions including documentation and third-party approvals. The facility is expected to close within Q2 2025. The contemplated sale and leaseback facility will have a tenor of 12 years and a 17-year amortization profile, with quarterly repayment installments throughout the lease period. Upon closing and repayment of the existing debt facility, Gimi MS Corporation is expected to generate net proceeds of approximately USD 530 million. This amount includes the release of existing interest rate swaps. Golar will benefit from...

VivoPower subsidiary, Caret Digital, to be spun off via a direct Nasdaq listing VivoPower shareholders as of a future record date, to receive 5 Caret Digital dividend shares per VivoPower share held Implied market capitalisation of $250m (subject to change depending on market conditions and quantum of capital raising) Caret Digital to focus on Dogecoin (DOGE) mining with BTC conversion to optimize returns and yield LONDON, March 20, 2025 (GLOBE NEWSWIRE) — VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) announced today that it has engaged advisors to support in executing its plan to spin off its subsidiary, Caret LLC (“Caret Digital”), through a direct listing on the Nasdaq Stock Market (“Nasdaq”). The decision to effectuate a spin off via a direct listing rather than...

ATHENS, Greece, March 20, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill Ocean Transportation (Singapore) Pte. Ltd., for one of its Ultramax dry bulk vessels, the m/v DSI Andromeda. The gross charter rate is US$14,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum November 15, 2025 up to maximum January 15, 2026. The charter is expected to commence on March 29, 2025. The m/v DSI Andromeda is currently chartered, as previously announced, to Bunge SA, Geneva, at a gross charter rate of US$13,500 per day, minus a 5.00% commission paid to third parties. The...

PITTSBURGH, March 20, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in photonics, announces the launch of its 2x400G-FR4 Lite optical transceiver, a silicon photonics-based module optimized for AI-driven data centers and high-speed Ethernet networks. Designed for high volume deployments, this transceiver delivers 500-meter reach while significantly reducing power consumption. It complements the company’s existing 800G-DR8 transceiver, also built with silicon photonics technology, with a wavelength-multiplexed variant that is more fiber-efficient than the DR8. The explosive growth of AI and ML workloads is driving demand for high-density, energy-efficient optical interconnects that seamlessly integrate with Ethernet-based front-end networks. The 2x400G-FR4 Lite is engineered to support these evolving architectures...

Scottsdale, Ariz., March 20, 2025 (GLOBE NEWSWIRE) — CISO Global, Inc. (NASDAQ: CISO), an industry leader in AI-powered cybersecurity software, managed cybersecurity, and compliance, today announced the successful deployment of Skanda, its next-generation penetration testing and security analysis tool. Designed to function beyond traditional vulnerability detection, Skanda leverages AI and machine learning (ML) technologies to provide continuous, on-demand security assessments, significantly enhancing cyber resilience for organizations worldwide. Skanda is part of CISO Global’s suite of proprietary intellectual property, which was independently valued at $50 million in 2024. It is currently utilized in all external penetration tests conducted by CISO Global’s security professionals and enhances internal penetration testing efforts,...

Conference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8:30 a.m. Eastern Time SEATTLE, March 20, 2025 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the Company will host a conference call and live audio webcast on Tuesday, March 25, 2025, at 8:30 a.m. ET, to discuss its corporate and financial results for the fourth quarter and full-year 2024. The webcast will be available at the investor relations section of the Company’s website at atossatherapeutics.com. Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator...